Sign In
Buy FBIO
$2.61
-0.0400 (-1.51%)
At Close: Jun 03, 2026
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
04:01pm, Wednesday, 01'st May 2024
SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily fo
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
08:30am, Thursday, 25'th Apr 2024
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
12:24pm, Thursday, 11'th Apr 2024
Biotech stocks can offer some of the most explosive, exciting opportunities on the market. That is, if you find the right one.
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
04:05pm, Thursday, 28'th Mar 2024
Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18 months FDA accepted New Drug Application filing
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
08:30am, Friday, 22'nd Mar 2024
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financ
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
04:01pm, Thursday, 21'st Mar 2024
Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
08:30am, Monday, 18'th Mar 2024
Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024 Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
08:30am, Friday, 15'th Mar 2024
Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
08:30am, Wednesday, 13'th Mar 2024
SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the sellin
Fortress Biotech to Participate in 36th Annual ROTH Conference
08:30am, Tuesday, 12'th Mar 2024
MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializi
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues
Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first FDA-approved treatment for Menkes disease
Best Penny Stocks To Buy This Week? 4 To Watch Now
10:17am, Monday, 20'th Nov 2023
Whether you're looking at the “ Magnificent Seven stocks ,” or just the next round of penny stocks to watch, news & company events can quickly sway sentiment. This week is a short holiday week wit
11 Top Penny Stocks To Buy Now According To Insiders
01:32pm, Friday, 17'th Nov 2023
Ever wonder what signals to look for in the stock market today? Let's talk about insider buying – a goldmine of clues that could lead you to the next prospect to add to your list of penny stocks to
Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023
08:30am, Tuesday, 31'st Oct 2023
Company to host conference call to discuss financial results and provide a corporate update on November 7, 2023 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide
